Immutep Limited (IMMP)
NASDAQ: IMMP · IEX Real-Time Price · USD
1.940
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
1.980
+0.040 (2.06%)
Pre-market: Jul 22, 2024, 7:28 AM EDT

Immutep Revenue

Immutep had revenue of $4.58M in the twelve months ending December 31, 2023. In the fiscal year ending June 30, 2023, Immutep had annual revenue of $3.59M.

Revenue (ttm)
$4.58M
Revenue Growth
-23.58%
P/S Ratio
53.54
Revenue / Employee
$147,637
Employees
31
Market Cap
245.05M USD

Revenue Chart

* The company reports in AUD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20233.59M-1.11M-23.58%
Jun 30, 20224.69M1.71M57.30%
Jun 30, 20212.98M-8.40M-73.78%
Jun 30, 202011.38M6.11M115.75%
Jun 30, 20195.27M-172.67K-3.17%
Jun 30, 20185.45M2.20M67.77%
Jun 30, 20173.25M1.74M114.92%
Jun 30, 20161.51M-102.31K-6.34%
Jun 30, 20151.61M-1.35M-45.47%
Jun 30, 20142.96M-704.67K-19.24%
Jun 30, 20133.66M-632.41K-14.72%
Jun 30, 20124.30M3.15M275.71%
Jun 30, 20111.14M699.68K157.75%
Jun 30, 2010443.55K420.00K1,783.04%
Jun 30, 200923.56K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Semler Scientific 65.88M
AVITA Medical 51.50M
Utah Medical Products 49.04M
Mersana Therapeutics 38.30M
Senseonics Holdings 23.30M
Cibus 2.32M
Atai Life Sciences 277.00K
Sera Prognostics 206.00K
Revenue Rankings